N-Isobutyl decanamide

CAS No. 73785-31-6

N-Isobutyl decanamide( —— )

Catalog No. M34668 CAS No. 73785-31-6

N-Isobutyl decanamide (N-Isobutyl N-decanamide) is an amphiphilic derivative belonging to the class of alkanamides with potential anti-inflammatory activity that promotes growth and alters root development in Arabidopsis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 122 In Stock
10MG 178 In Stock
25MG 297 In Stock
50MG 431 In Stock
100MG 634 In Stock
200MG Get Quote In Stock
500MG 1330 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-Isobutyl decanamide
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Isobutyl decanamide (N-Isobutyl N-decanamide) is an amphiphilic derivative belonging to the class of alkanamides with potential anti-inflammatory activity that promotes growth and alters root development in Arabidopsis.
  • Description
    N-Isobutyl decanamide (N-Isobutyl N-decanamide) is an amphiphilic derivative belonging to the class of alkanamides with potential anti-inflammatory activity that promotes growth and alters root development in Arabidopsis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    73785-31-6
  • Formula Weight
    227.39
  • Molecular Formula
    C14H29NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NCC(C)C)CCCCCCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Noreugenin

    Noreugenin is a new chromone from Hymenocallis littoralis Salisb.?

  • Fresolimumab

    Fresolimumab (GC1008) is a specific human anti-transforming growth factor β monoclonal antibody that binds to the active forms of human TGFβ1, TGFβ2, and TGFβ3 and can be used to study focal segmental glomerulosclerosis and cancer in adults.

  • BC-LI-0186

    BC-LI-0186 is a potent and selective inhibitor of the interaction of Leucyl-tRNA synthetase (LRS) and Ras-related GTP-binding protein D (RagD) with IC50 of 46.11 nM.